Kforce Clinical Research Wins Operational Award from Merck
Kforce Clinical Research, a division of Kforce, Inc. (NASDAQ: KFRC), has won Merck & Co. Inc.'s "Outstanding Operational Award in Clinical Development" as part of Merck's 2007 Supplier Recognition Awards.
Kforce Clinical Research Wins Operational Award from Merck
TAMPA, Fla. – (Sept. 10, 2008) – Kforce Clinical Research, a division of Kforce, Inc. (NASDAQ: KFRC), has won Merck & Co. Inc.’s “Outstanding Operational Award in Clinical Development” as part of Merck's 2007 Supplier Recognition Awards. Kforce Clinical Research was one of 13 suppliers to be recognized at the pharmaceutical company’s Annual Supplier Recognition Forum at their headquarters in Whitehouse Station, N.J., on June 12.
Four years ago Merck established its “Plan to Win” program. In June of this year, Merck invited 75 suppliers to the Recognition Forum where key executives discussed Merck’s critical initiatives and these suppliers’ role in helping Merck achieve its Plan to Win. Ultimately, 13 suppliers were identified for their accomplishments in this initiative.
Kforce Clinical Research provides customized and flexible functional outsourcing solutions to the biopharmaceutical industry. It specializes in clinical monitoring, site and study management, drug safety, clinical data management, data entry, clinical programming and biostatistics. Where as other outsourcing providers either augment a company’s drug trial with people or handle all aspects of the trial, Kforce’s functional outsourcing model offers a flexible, tailored approach developed to mirror each company’s business model and address specific requirements of the drug trial itself.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
